Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients

• Published in: Zhōnghuá xīnxuèguănbìng zázhì Vol. 48; no. 6; p. 456
• Main Authors: He, X W, Lai, J S, Cheng, J, Wang, M W, Liu, Y J, Xiao, Z C, Xu, C, Li, S S, Zeng, H S
• Format: Journal Article
• Language: Chinese
• Published: China 24.06.2020
• Subjects: Aged; Betacoronavirus; Coronavirus Infections - complications; COVID-19; Critical Illness; Heart Injuries; Humans; Middle Aged; Pandemics; Pneumonia, Viral - complications; Retrospective Studies; SARS-CoV-2; COVID-19; Troponin; Myocardial injury
• ISSN: 0253-3758
• DOI: 10.3760/cma.j.cn112148-20200228-00137

To analyze the clinical characteristics of the severe or critically ill patients with novel coronavirus pneumonia (COVID-19), and evaluate the impact of complicated myocardial injury on the prognosis of these patients. A retrospective study was conducted in 54 patients who admitted to Tongji hospital from February 3, 2020 to February 24, 2020 and met the criteria of severe or critical conditions of COVID-19. The clinical characteristics and hospital mortality rate were analyzed and compared between the patients with or without myocardial injury, which was defined with 3 times higher serum cardiac troponin value. The age of the 54 patients was 68.0(59.8, 74.3) years. Among all the patients, 24 (44.4%) patients were complicated with hypertension, 13 (24.1%) with diabetes, 8 (14.8%) with coronary heart disease, and 3 (5.6%) with previous cerebral infarction. During hospitalization, 24 (44.4%) of the patients were complicated with myocardial injury and 26 (48.1%) patients died in hospital. In-hospital mortality was significantly higher in patients with myocardial injury than in patients without myocardial injury (14 (60.9%) vs. 8 (25.8%), =0.013). Moreover, the levels of C-reactive protein (153.6 (80.3, 240.7) ng/L vs. 49.8 (15.9, 101.9) ng/L) and N-terminal pro-B-type natriuretic peptide (852.0 (400.0, 2 315.3) ng/L vs. 197.0 (115.3, 631.0) ng/L) were significantly higher than patients without myocardial injury (all <0.01). Prevalence of myocardial injury is high among severe or critically ill COVID-19 patients. Severe or critically ill COVID-19 patients with myocardial injury face a significantly higher risk of in-hospital mortality. The study suggests that it is important to monitor and manage the myocardial injury during hospitalization for severe or critically ill COVID-19 patients.